Discover my journey to becoming one of OBN’s new Board Observers! OBN is the premier network for the UK’s innovative life sciences companies. I delve into the key lessons that shaped my approach to the interview and share how I plan to leverage this role to amplify the voices of emerging entrepreneurs.

Explore the innovative "More Research, Less Cancer" campaign launched by Cancer Research UK, emphasizing its visionary approach to addressing the urgent need for advancements in cancer research. It sheds light on the significant funding gap within the field and the campaign's efforts to foster collaboration and innovation across the scientific community.

Unlock the secrets of academia's leap into commercialization. Dive into the pivotal insights from the Oxford case and implications of the UK’s independent review of university spin-out companies. Explore the future of university ventures through UCL’s Institute of Brand and Innovation Law conference.

Two meetings, one day: Expert 003 schooled me on IP alignment and team-building, while Expert 004 tackled the real deal on equity and the market's pulse. Navigated the crossroads of postdoc CEO potential and scalable models with a side of surprise.

Exciting times ahead for UK medical device innovators! The MHRA's new roadmap is paving the way for a more harmonised regulatory environment, closely aligning with EU standards. This is particularly crucial for us in the IVD sector, ensuring our innovations reach patients safely and efficiently. Key takeaways include the introduction of Unique Device Identifiers (UDI) and enhanced Post-Market Surveillance (PMS), which are game-changers for maintaining device safety.

In a recent meeting with a pharma veteran, we dissected the strategic intricacies of bringing a diagnostic tool to the clinic. We delved into what influences a pharmaceutical company’s choice of diagnostic tests and how to keep an innovation both scalable and clinically relevant. This conversation was a deep dive into the practical challenges and considerations of diagnostic development, revealing the delicate balance between scientific discovery and market strategy.

Navigating the labyrinth world of diagnostics with an industry expert.

Dive into my journey at The Crick's Diagnostics Symposium, where innovation wasn't just a buzzword but a tangible presence in every conversation and presentation.

Welcome to my entrepreneurial odyssey in the translationsphere— a mix of failure, struggle, and rare success. Join me as I navigate through fascinating encounters, complex systems, and invaluable lessons, all chronicled in my raw, unfiltered notes.